Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alector

Alector
2013 FOUNDED
PUBLIC STATUS
71-80 EMPLOYEES
ALEC STOCK SYMBOL
$18.84 SHARE PRICE (As of Friday Closing)
Description

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 151 Oyster Point Boulevard
  • Suite 300
  • South San Francisco, CA 94080
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alector’s full profile, request a free trial.

Alector Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$15.16 - $27.00 $1.3B $18.75 -$0.91 123K 68.9M

Alector Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,209,392
Revenue 28,362 27,677 3,735 416
EBITDA (61,266) (51,229) (31,800) (14,909)
Net Income (62,371) (52,248) (32,480) (15,110)
Total Assets 496,044 308,359 236,060 54,111
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Alector Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alector‘s full profile, request access.

Request full access to PitchBook

Alector Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Denali Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
000000000 Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
0000000 Venture Capital-Backed CA 000.00 00000000000 000.00
00000 Venture Capital-Backed Pittsburgh, PA 00 0000 0000000000 0 0000
000000 00000000000 Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
To view this company’s complete list of competitors, request access »

Alector Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Alector‘s full profile, request access.

Request full access to PitchBook

Alector Executive Team (15)

Name Title Board
Seat
Contact
Info
Arnon Rosenthal Ph.D Co-Founder, Chief Executive Officer & Board Member
Sabah Oney Ph.D Chief Business Officer
Tillman Gerngross Ph.D Chairman & Co-Founder
Calvin Yu Vice President, Finance
Stephanie Yonker Ph.D Vice President, Legal

5 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

Alector Board Members (15)

Name Representing Role Since Contact
Info
Arnon Rosenthal Ph.D Alector Co-Founder, Chief Executive Officer & Board Member 000 0000
Carl Gordon Ph.D OrbiMed Board Member 000 0000
Christine Brennan Ph.D MRL Ventures Fund Board Member 000 0000
David Wehner Self Board Member 000 0000
James Sullivan Ph.D AbbVie Ventures Board Observer 000 0000

1 Former Board Member

You’re viewing 5 of 15 board members. Get the full list »